Journal article
In vivo Dual Substrate Bioluminescent Imaging
Journal of visualized experiments, Vol.56, e3245
10/11/2011
DOI: 10.3791/3245
PMCID: PMC3227190
PMID: 22006228
Abstract
Our understanding of how and when breast cancer cells transit from established primary tumors to metastatic sites has increased at an exceptional rate since the advent of in vivo bioluminescent imaging technologies(1-3). Indeed, the ability to locate and quantify tumor growth longitudinally in a single cohort of animals to completion of the study as opposed to sacrificing individual groups of animals at specific assay times has revolutionized how researchers investigate breast cancer metastasis. Unfortunately, current methodologies preclude the real-time assessment of critical changes that transpire in cell signaling systems as breast cancer cells (i) evolve within primary tumors, (ii) disseminate throughout the body, and (iii) reinitiate proliferative programs at sites of a metastatic lesion. However, recent advancements in bioluminescent imaging now make it possible to simultaneously quantify specific spatiotemporal changes in gene expression as a function of tumor development and metastatic progression via the use of dual substrate luminescence reactions. To do so, researchers take advantage for two light-producing luciferase enzymes isolated from the firefly (Photinus pyralis) and sea pansy (Renilla reniformis), both of which react to mutually exclusive substrates that previously facilitated their wide-spread use in in vitro cell-based reporter gene assays(4). Here we demonstrate the in vivo utility of these two enzymes such that one luminescence reaction specifically marks the size and location of a developing tumor, while the second luminescent reaction serves as a means to visualize the activation status of specific signaling systems during distinct stages of tumor and metastasis development. Thus, the objectives of this study are two-fold. First, we will describe the steps necessary to construct dual bioluminescent reporter cell lines, as well as those needed to facilitate their use in visualizing the spatiotemporal regulation of gene expression during specific steps of the metastatic cascade. Using the 4T1 model of breast cancer metastasis, we show that the in vivo activity of a synthetic Smad Binding Element (SBE) promoter was decreased dramatically in pulmonary metastasis as compared to that measured in the primary tumor(4-6). Recently, breast cancer metastasis was shown to be regulated by changes within the primary tumor microenvironment and reactive stroma, including those occurring in fibroblasts and infiltrating immune cells(7-9). Thus, our second objective will be to demonstrate the utility of dual bioluminescent techniques in monitoring the growth and localization of two unique cell populations harbored within a single animal during breast cancer growth and metastasis.
Details
- Title: Subtitle
- In vivo Dual Substrate Bioluminescent Imaging
- Creators
- Michael K. Wendt - Case Western Reserve UniversityJoseph Molter - Case Western Reserve UniversityChristopher A. Flask - Case Western Reserve UniversityWilliam P. Schiemann - Case Western Reserve University
- Resource Type
- Journal article
- Publication Details
- Journal of visualized experiments, Vol.56, e3245
- DOI
- 10.3791/3245
- PMID
- 22006228
- PMCID
- PMC3227190
- NLM abbreviation
- J Vis Exp
- ISSN
- 1940-087X
- eISSN
- 1940-087X
- Publisher
- Journal Of Visualized Experiments
- Number of pages
- 5
- Grant note
- P30DK027651 / NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) BC084561 / Department of Defense; United States Department of Defense Case Center for Imaging Research R01CA129359 / NATIONAL CANCER INSTITUTE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI) BCTR0706967 / Susan G. Komen for the Cure Foundation; Susan G. Komen Breast Cancer Foundation Seidman Cancer Center P30 DK027651 / Cystic Fibrosis Center CA129359 / National Institutes of Health; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA PF-09-120-01 / American Cancer Society P30 CA43703 / Case Comprehensive Cancer Center
- Language
- English
- Date published
- 10/11/2011
- Academic Unit
- Internal Medicine
- Record Identifier
- 9984460326402771
Metrics
3 Record Views